These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10172966)

  • 1. Healthcare technology assessment and the challenge to pharmacoeconomics in Japan.
    Hisashige A
    Pharmacoeconomics; 1997 Apr; 11(4):319-33. PubMed ID: 10172966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why has the use of health economic evaluation in Japan lagged behind that in other developed countries?
    Ikegami N; Drummond M; Fukuhara S; Nishimura S; Torrance GW; Schubert F
    Pharmacoeconomics; 2002; 20 Suppl 2():1-7. PubMed ID: 12238943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Japan's aging population. Implications for healthcare.
    Oliver AJ; Ikegami N; Ikeda S
    Pharmacoeconomics; 1997 Apr; 11(4):306-18. PubMed ID: 10172965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Japan's healthcare policy for the elderly through the concepts of self-help (Ji-jo), mutual aid (Go-jo), social solidarity care (Kyo-jo), and governmental care (Ko-jo).
    Sudo K; Kobayashi J; Noda S; Fukuda Y; Takahashi K
    Biosci Trends; 2018 Mar; 12(1):7-11. PubMed ID: 29479017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Information barriers to the implementation of economic evaluations in Japan.
    Nishimura S; Torrance GW; Ikegami N; Fukuhara S; Drummond M; Schubert F
    Pharmacoeconomics; 2002; 20 Suppl 2():9-15. PubMed ID: 12238944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New decision-making processes for the pricing of health technologies in Japan: The FY 2016/2017 pilot phase for the introduction of economic evaluations.
    Shiroiwa T; Fukuda T; Ikeda S; Takura T
    Health Policy; 2017 Aug; 121(8):836-841. PubMed ID: 28687183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practical aspects of designing and conducting pharmacoeconomic studies in Japan.
    Doherty J; Sato K
    Pharmacoeconomics; 2003; 21(13):913-25. PubMed ID: 12959624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Development and Practice of Pharmacoeconomic Evaluation Guidelines for Universal Health Coverage in China.
    Yue X; Li Y; Wu J; Guo JJ
    Value Health Reg Issues; 2021 May; 24():1-5. PubMed ID: 33349598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future of Japan's system of good health at low cost with equity: beyond universal coverage.
    Shibuya K; Hashimoto H; Ikegami N; Nishi A; Tanimoto T; Miyata H; Takemi K; Reich MR
    Lancet; 2011 Oct; 378(9798):1265-73. PubMed ID: 21885100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health care expenditures for the elderly and reforms in the health care system in Japan.
    Kobayashi Y
    Health Policy; 1994 Sep; 29(3):197-208. PubMed ID: 10138724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health technology assessment in Japan: a work in progress.
    Kamae I; Thwaites R; Hamada A; Fernandez JL
    J Med Econ; 2020 Apr; 23(4):317-322. PubMed ID: 31944134
    [No Abstract]   [Full Text] [Related]  

  • 12. Healthcare system in Japan.
    Yamauchi T
    Nurs Health Sci; 1999 Mar; 1(1):45-8. PubMed ID: 10894651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is next for pharmacoeconomics and outcomes research in Asia?
    Doherty J; Kamae I; Lee KK; Li H; Li SC; Liu GG; Tarn YH; Yang BM
    Value Health; 2004; 7(2):118-32. PubMed ID: 15164802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Japanese healthcare system: lessons to be learned.
    Ikegami N
    Expert Rev Pharmacoecon Outcomes Res; 2009 Jun; 9(3):201-4. PubMed ID: 19527091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Economic Issues of Hemodialysis Therapy within the Japanese Health Care System.
    Takemoto Y; Naganuma T
    Contrib Nephrol; 2017; 189():257-261. PubMed ID: 27951577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacoeconomics].
    Shiragami M
    Yakugaku Zasshi; 2003 Mar; 123(3):133-42. PubMed ID: 12693013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.
    Arai H; Ouchi Y; Toba K; Endo T; Shimokado K; Tsubota K; Matsuo S; Mori H; Yumura W; Yokode M; Rakugi H; Ohshima S
    Geriatr Gerontol Int; 2015 Jun; 15(6):673-87. PubMed ID: 25656311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Japan's advanced medicine.
    Sho R; Narimatsu H; Murakami M
    Biosci Trends; 2013 Oct; 7(5):245-9. PubMed ID: 24241175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review of economic evaluation literature in Thailand: are the data good enough to be used by policy-makers?
    Teerawattananon Y; Russell S; Mugford M
    Pharmacoeconomics; 2007; 25(6):467-79. PubMed ID: 17523752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The truth lies somewhere in the middle: Swinging between globalization and regionalization of medical education in Japan.
    Saiki T; Imafuku R; Suzuki Y; Ban N
    Med Teach; 2017 Oct; 39(10):1016-1022. PubMed ID: 28758830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.